Medicinal leech antimicrobial peptides lacking toxicity represent a promising alternative strategy to combat antibiotic-resistant pathogens.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
15 Oct 2019
Historique:
received: 22 05 2019
revised: 27 06 2019
accepted: 27 06 2019
pubmed: 16 7 2019
medline: 5 11 2019
entrez: 15 7 2019
Statut: ppublish

Résumé

The rise of antibiotic resistance has necessitated the development of alternative strategies for the treatment of infectious diseases. Antimicrobial peptides (AMPs), components of the innate immune response in various organisms, are promising next-generation drugs against bacterial infections. The ability of the medicinal leech Hirudo medicinalis to store blood for months with little change has attracted interest regarding the identification of novel AMPs in this organism. In this study, we employed computational algorithms to the medicinal leech genome assembly to identify amino acid sequences encoding potential AMPs. Then, we synthesized twelve candidate AMPs identified by the algorithms, determined their secondary structures, measured minimal inhibitory concentrations against three bacterial species (Escherichia coli, Bacillus subtilis, and Chlamydia thrachomatis), and assayed cytotoxic and haemolytic activities. Eight of twelve candidate AMPs possessed antimicrobial activity, and only two of them, 3967 (FRIMRILRVLKL) and 536-1 (RWRLVCFLCRRKKV), exhibited inhibition of growth of all tested bacterial species at a minimal inhibitory concentration of 10 μmol. Thus, we evidence the utility of the developed computational algorithms for the identification of AMPs with low toxicity and haemolytic activity in the medicinal leech genome assembly.

Identifiants

pubmed: 31302447
pii: S0223-5234(19)30607-5
doi: 10.1016/j.ejmech.2019.06.080
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Antimicrobial Cationic Peptides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

143-153

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

E N Grafskaia (EN)

Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russia; Moscow Institute of Physics and Technology (National Research University), Dolgoprudny, 141700, Russia. Electronic address: ekaterina.grafskaya@phystech.edu.

K D Nadezhdin (KD)

Moscow Institute of Physics and Technology (National Research University), Dolgoprudny, 141700, Russia; M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia.

I A Talyzina (IA)

M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia; Federal State Budget Educational Institution of Higher Education, M.V.Lomonosov Moscow State University (Lomonosov MSU), Moscow, 119991, Russia.

N F Polina (NF)

Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russia.

O V Podgorny (OV)

Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russia; Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Moscow, 119991, Russia.

E R Pavlova (ER)

Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russia; Moscow Institute of Physics and Technology (National Research University), Dolgoprudny, 141700, Russia.

P V Bashkirov (PV)

Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russia.

D D Kharlampieva (DD)

Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russia.

P A Bobrovsky (PA)

Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russia.

I A Latsis (IA)

Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russia.

V A Manuvera (VA)

Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russia; Moscow Institute of Physics and Technology (National Research University), Dolgoprudny, 141700, Russia.

V V Babenko (VV)

Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russia.

V M Trukhan (VM)

Sechenov First Moscow State Medical University (Sechenov University), Moscow, 119146, Russia.

A S Arseniev (AS)

Moscow Institute of Physics and Technology (National Research University), Dolgoprudny, 141700, Russia; M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, 117997, Russia.

D V Klinov (DV)

Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russia.

V N Lazarev (VN)

Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, 119435, Russia; Moscow Institute of Physics and Technology (National Research University), Dolgoprudny, 141700, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH